Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of EGb 761 for protection against temporary noise-induced hearing impairment
2013-000614-38Phase 2Completed
- Sponsor
- Schwabe Group
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in noise-induced hearing loss (NIHL) comparing EGb 761 with Placebo (2 arms). Primary endpoint: Mean increase in auditory threshold after noise exposure. Started Aug 2013; status: completed.
02
Drugs
ginkgo biloba extract
03
Conditions
noise-induced hearing loss (NIHL)
Beyond the preview
Go deeper on 2013-000614-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000614-38.